Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration of shared biomarkers and mechanisms in systemic lupus erythematous and lung cancer via bioinformatics analysis. | J Transl Autoimmun | 2025 | 40810050 | PubTator, text mining | PubMed |
| From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence. | Front Bioeng Biotechnol | 2025 | 40809065 | PubTator, text mining | PubMed |
| Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer. | Front Oncol | 2025 | 40792276 | PubTator, text mining | PubMed |
| 5-aminolaevulinic acid combined with sodium ferrous citrate ameliorated collagen-induced arthritis via anti-inflammatory effects and fibroblast-like synoviocytes-driven B cell immunomodulation. | Int Immunopharmacol | 2025 | 40784275 | PubTator, text mining | PubMed |
| Temozolomide Resistance in Smoking-Related Bladder Cancer through TNFAIP6-Mediated Post-Translational Modifications. | Arch Esp Urol | 2025 | 40776873 | PubTator, text mining | PubMed |
| Construction and characteristics of an adjustable biomechanical in vitro corneal stromal model simulating keratoconus pathological features. | Mater Today Bio | 2025 | 40761516 | PubTator, text mining | PubMed |
| Network analysis of master regulators associated with invasive phenotypes in multiple myeloma. | Front Cell Dev Biol | 2025 | 40741330 | PubTator, text mining | PubMed |
| Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. | Burns Trauma | 2025 | 40740686 | PubTator, text mining | PubMed |
| Inflammatory priming of mesenchymal stromal cells enhances its secretome potential through secretion of anti-inflammatory and ECM modulating factors: Insights into proteomic and functional properties. | Biochem Biophys Res Commun | 2025 | 40716306 | PubTator, text mining | PubMed |
| N-glycosylation stabilized TNFAIP6 promotes ovarian cancer metastasis by activating the PI3K-AKT signaling pathway. | Cell Signal | 2025 | 40701312 | PubTator, text mining | PubMed |
| Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease. | Ren Fail | 2025 | 40653823 | PubTator, text mining | PubMed |
| TSG6 impacts the immune microenvironment and drug sensitivity in gastric cancer. | Rev Assoc Med Bras (1992) | 2025 | 40638477 | PubTator, text mining | PubMed |
| Engineering strategies to enhance the research progress of mesenchymal stem cells in wound healing. | Stem Cell Res Ther | 2025 | 40598499 | PubTator, text mining | PubMed |
| CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer. | Sci Rep | 2025 | 40596054 | PubTator, text mining | PubMed |
| Genetic mutation and blue rubber bleb nevus syndrome: case reports and literature review. | Front Genet | 2025 | 40584829 | PubTator, text mining | PubMed |
| Key mediators of the efficacy of mesenchymal stem cells on in vivo disease models. | Cell Transplant | 2025 | 40560652 | PubTator, text mining | PubMed |
| The combination of FLI, ITS, pFF, and citrate improves the developmental potential of gilt oocytes during in vitro maturation. | Anim Reprod Sci | 2025 | 40543209 | PubTator, text mining | PubMed |
| Revealing Potential Therapeutic Targets in Gastric Cancer through Inflammation and Protein-Protein Interaction Hub Networks. | J Cancer | 2025 | 40535808 | PubTator, text mining | PubMed |
| Dysfunctional pericellular hyaluronan deposition contributes to attenuated CD44/EGFR co-localization and impaired myofibroblast differentiation in chronic wound fibroblasts. | Exp Cell Res | 2025 | 40523596 | PubTator, text mining | PubMed |
| Systemic immune response alteration in patients with severe pressure ulcers. | Sci Rep | 2025 | 40467704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=5